Unusual patterns of presentation of frontal fibrosing alopecia: A clinical and trichoscopic analysis of 98 patients
To the Editor: Frontal fibrosing alopecia (FFA) is a primary lymphocytic scarring alopecia that mainly affects postmenopausal women. 1 In the past 2 decades, an increasing number of cases have been reported. 2 Recognizing FFA may be a challenge when it manifests with unusual features.
The aim of this study was to evaluate clinical and trichoscopic features of FFA in a large series of patients.
We performed a retrospective, monocentric study of trichoscopic images of 98 patients (4 men and 94 women) with FFA seen at our Dermatologic Clinic between 2003 and 2016. The diagnosis of FFA was based on clinical (symmetric frontal or frontotemporal hairline recession) and typical trichoscopic findings (absence of follicular openings, lone hairs, and single-hair pilosebaceous units). All patients were white, without familial history of FFA. Two patients were premenopausal at the onset.
In our case series in 80 patients, FFA manifested with typical clinical features, whereas in 18 postmenopausal patients (18.4%), we observed unusual patterns of disease. In particular, 12 women presented with marked and symmetric recession of frontotemporal hairlines, with a peculiar sparing of the paramedian frontal hairline, mimicking male pattern androgenetic alopecia (AGA). We named this peculiar clinical presentation ''AGA-like pattern'' (Fig 1, A and C ) . Trichoscopic examination revealed typical findings of FFA (Fig 1, B and D) . Moreover, in 2 patients we observed bilateral oval patches of alopecia in the temporal regions, with peculiar sparing of a band of temporal hairlines, in addition to typical recession of frontal hairline (Fig 2, A) . fibrosing alopecia (male androgenetic alopecia-like pattern) (A and C). Two cases of female patients had marked and symmetric recession of frontotemporal hairlines, with a peculiar sparing of the paramedian part of frontal hairline and the presence of bandlike atrophic areas with some terminal hairs in scarring outcome (black arrows). Frontal fibrosing alopecia (male androgenetic alopecia-like pattern) (B and D). Trichoscopic examination: scarring white patches with lack of follicular openings (green arrows), mild perifollicular scaling and erythema (red arrows), and some terminal hairs and single-hair pilosebaceous units (black arrows).
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Trichoscopy revealed typical findings of FFA, leading to a diagnosis of FFA in a peculiar clinical pattern that we called ''cockade-like pattern'' (Fig 2, B) . Continuous involvement of the hairline from frontal to occipital regions was present in 6 other patients (Fig 2, C ) . Trichoscopic examination revealed in 4 of 6 cases typical findings of FFA at all areas affected (Fig 2, D) . We termed this clinical finding ''ophiasislike pattern.'' Instead, in 2 of 6 cases, trichoscopic examination revealed signs of alopecia areata at the occipital region, whereas typical features of FFA were present at the frontotemporal and retroauricolar regions.
Trichoscopy is a fast, noninvasive, and costefficient technique that is very useful in the diagnosis of hair and scalp diseases. 3 In particular, its efficacy has been demonstrated to diagnose and differentiate alopecia areata from other patchy alopecia and to diagnose early AGA. 3 Recently, Fern andez-Crehuet et al 4 considered trichoscopy a valuable tool also in the diagnosis of FFA. The main trichoscopic features of FFA are absence of follicular openings, scarring white patches, minor perifollicular scaling, perifollicular erythema, and lone hairs. 4 Va n o-Galv an et al 5 reported that typical dermoscopic features could substitute for biopsy in patients with typical FFA.
We observed in a large case series that 18.4% of patients affected by FFA had unusual clinical findings; we could identify 3 patterns: (1) AGA-like pattern; (2) cockade-like pattern; and (3) ophiasislike pattern. Trichoscopy revealed in all patients affected by FFA, both with typical and unusual clinical patterns, the same repetitive findings, namely the absence of follicular openings, scattered lone hairs, and single-hair pilosebaceous units at margins, also suggesting that when clinical presentation is not conclusive for the diagnosis of FFA, trichoscopy may be a very useful tool in the differential diagnosis. Rotterdam criteriaebased diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A crosssectional study To the Editor: Polycystic ovary syndrome (PCOS) has historically been associated with prominent skin findings, including hirsutism, acanthosis nigricans (AN), acne, and androgenic alopecia (AGA), as well as systemic findings. The Rotterdam PCOS diagnostic criteria require 2 of 3 features-biochemical or clinical hyperandrogenism (HA), oligoanovulation (OA), and polycystic ovaries (PCO) 1 -resulting in 4 PCOS diagnostic subtypes (Table I) . Whether PCOS subtypes have distinct skin findings and cardiometabolic profiles is poorly understood. The clinical significance and long-term prognosis of these subtypes remain controversial.
We performed a cross-sectional study of a cohort of 255 women meeting the Rotterdam criteria for PCOS to determine skin and metabolic phenotypes among different PCOS subtypes. HA was defined by cutaneous presentation (hirsutism) or biochemical HA (ie, elevated androgens). The prevalence of skin findings among PCOS subtypes was strikingly similar (Table I) . This remained true, even for hirsutism, when PCOS subtypes were defined by biochemical HA alone rather than biochemical HA or hirsutism (data not shown). Older age mitigates the cutaneous phenotype in PCOS 2 ; there were no significant differences in age among subtypes (data not shown). There was a trend toward reduced prevalence of AN in the OA 1 PCO subtype (ie, patients lacking evidence of hyperandrogenism) but no significant differences in other skin findings.
Metabolic phenotype, specifically cardiometabolic risk profile, was not differentially associated with PCOS subtypes (data not shown). However, as previously observed, 3, 4 the OA 1 PCO subtype had a nonsignificant trend toward a more favorable cardiometabolic profile, including improved lipid markers and reduced insulin resistance.
Because PCOS subtypes did not strongly differ in their skin findings or cardiometabolic risk profiles, we examined the effects of biochemical HA and obesity on clinical phenotype. Biochemical HA and obesity were not associated with one another ( 2 ; P ¼ .90, data not shown). Body mass index was similar among PCOS subtypes (data not shown). Obesity was significantly associated with metabolic abnormalities and increased cutaneous findings, specifically hirsutism, AN, and AGA (Table II) . Biochemical HA was associated with a trend in certain metabolic and cutaneous abnormalities (AN). The association of AN with both biochemical HA and obesity corroborates data suggesting that AN may indicate increased clinical severity among women with PCOS. 5 Hirsutism, acne, and AGA were not associated with a pooled measure of biochemical HA (Table II) . However, the association between free testosterone alone and hirsutism has been previously reported. 5 This likely reflects a stronger association between free testosterone and cutaneous HA than exists for other androgens.
PCOS subtypes are not strong predictors of cutaneous or metabolic phenotype; the role of hyperandrogenism as an independent phenotypic determinant remains unclear. Indeed, these and other 3, 4 findings challenge whether OA 1 PCO should be considered a subtype of PCOS given its milder phenotype. In addition, while obesity is not a
